Advertisement
Advertisement
July 2010
An Interview With Benjamin W. Starnes, MD
Dr. Starnes discusses his military physician training and his closure protocol for EVAR patients.
What was unique about your vascular training at
Walter Reed Army Medical Center? How did this
experience shape your eventual practice at the
University of Washington?
I am deeply proud of my military training. I believe that
any training in a military environment is rather unique.
There is a belief that military hospitals are the same as VA
hospitals and, although there are some similarities between
the systems, they are actually quite different. There are currently
only six major US Army Medical Centers in the
United States. These hospitals care not
only for active duty soldiers but also their
dependents to include spouses and children.
Also cared for is a huge population
of military retirees—in essence, patients
of all ages are cared for in these hospitals,
which offer comprehensive medical and
surgical training.
On the morning of September 11, 2001, while at Walter Reed, I was dispatched to the scene of the Pentagon to treat casualties and perform triage. Over the course of my military career, I have had a total of three combat tours, one to Kosovo and two to Iraq, where I gained a lot of experience in managing war wounds and vascular injuries. When I decided to go to the University of Washington as Chief of the Division of Vascular Surgery, I felt that Harborview, a level 1 trauma center for a vast five-state region, was a good fit for me and would allow me to transfer some of the experience I had gained on the battlefield to a civilian setting. I am extremely pleased with my choice. I couldn't work at a better institution or with more professional colleagues.
What is your most memorable experience as a military
physician?
Aside from 9/11, operating on a 2-hour-old newborn girl,
who was born with a tracheoesophageal fistula in a combat
zone, was unforgettable. Having been deployed for a second
time to Operation Iraqi Freedom with my wife 6 months
pregnant with our second daughter, this newborn tugged at
my heartstrings. She would have likely died because there
were no surgeons who had any experience with this sort of
problem at this hospital in Kirkuk. Their solution was to
send her to Baghdad, which would have taken her family
4 to 5 days—not an option in my mind. All of the years of
training culminated with a simple thoracotomy and
extrapleural repair. I am proud of the general surgery training
I received to save that girl. She is now 7 years old.
What initially prompted your decision to routinely
employ rapid right ventricular (RV) pacing for thoracic
endovascular aneurysm repair (TEVAR) procedures?
We had a patient who was undergoing TEVAR for a ruptured
aortic dissection who unfortunately experienced a retrograde
dissection (confirmed with intravascular ultrasound)
and died on the table. I gained a lot of respect for
those incredibly fragile aortic catastrophes and began to
look at ways to deploy grafts more accurately and with less
movement of the device. Based on the
experience of others, we tried rapid RV pacing
on our next difficult patient, and I was
amazed at the simplicity and preciseness of
the graft deployment. Although it is not
employed for every case, we use it when we
have a concern for retrograde dissection or
when millimeters make a difference.
How has rapid RV pacing changed
your day-to-day approach to thoracic
repair, as well as your results?
We use it for cases in which we are concerned
about retrograde dissection, such as penetrating
ulcers with intramural hematomas that extend retrograde
into the transverse arch or with dissections as I described
previously. We also use it when precise deployment is critical.
We have not experienced another retrograde dissection
since using this approach, and I have been happy with the
precision of graft deployment in the difficult cases.
What types of information do you rely on when making
practice-altering decisions on how to treat
patients with thoracic dissections? If published clinical
data differ from your own experiences, to what degree
do they influence whether to treat a particular patient
with open surgery versus an endovascular approach?
At the University of Washington, we see a high volume of
these cases in conjunction with our cardiothoracic surgeons.
Our routine practice is to divide these patients into
complicated and uncomplicated dissections. We manage
virtually all uncomplicated dissections with medical therapy
to include anti-impulse therapy. For the complicated dissections
(those with a malperfusion syndrome), we use a combination
of techniques to include stent grafting the entry
tear or performing fenestration to equalize the pressures
between true and false lumens. We have had excellent
results using this approach and rarely perform open surgery for these terribly sick patients. The other patients that we
treat are those who have acute dissections with contained
rupture and chronic dissections with aneurysmal degeneration
who are not good candidates for open surgical repair.
I believe that we, as academic surgeons, need to look at the
current literature on balance and compare it with our own
experiences—the truth lies somewhere in between.
What is the greatest area in which there is still room
for improvement in currently available TEVAR
devices in the aneurysm setting?
I would like to see more conformable devices that are
delivered through smaller delivery systems with the ability
to preserve branch vessels. There are a few companies
that have developed more conformable devices, and I am
excited to see how they perform over time. In the trauma
setting, an absorbable device would be ideal.
In type B dissections?
Aortic dissections are highly variable and extremely
complex. I don't believe that there can be a standard procedure
for all of these patients because they are all so
immeasurably different. Dissections require the physician
to be adept at thinking outside the box and solving the
problem on the fly with a combination of techniques. I do
strongly believe that complicated aortic dissections should
be approached first with an entirely endovascular method.
Intravascular ultrasound is absolutely mandatory. An
appreciation for physiology is also important in planning
the method of repair/stabilization.
What is your closure protocol when treating
patients using EVAR? What patient characteristics
do you look for before the procedure in order to
plan closure?
We now approach nearly every single patient percutaneously.
This includes patients with ruptured aneurysms,
and I think this has given us a time advantage in this terribly
ill patient population. It takes minutes to preclose. I use
a single 10-F Prostar XL device (Abbott Vascular, Santa
Clara, CA) to close arteriotomies up to 24 F. I generally do
not use this approach in patients who have severe occlusive
disease in the common femoral artery with an intraluminal
diameter of < 3.3 mm (which is the diameter of the
Prostar device). These patients are typically not EVAR candidates
anyway due to iliac occlusive disease. The default is
a groin cutdown, and I believe that it is at least worth a try
in every patient. Morbidly obese patients stand to benefit
the most from this approach, which should probably be
avoided early in an interventionist's experience, because
these patients can be the most difficult and their anatomy
hides a retroperitoneal hemorrhage better than a thin
patient.
Advertisement
Advertisement